Lung Health After Tuberculosis: Clinical and Functional Assessment in Post Pulmonary Tuberculosis Egyptian Patients.
1 other identifier
observational
210
1 country
1
Brief Summary
Some of pulmonary tuberculous patients who completed their medication course experience lung function impairment
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 20, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 4, 2020
CompletedFirst Submitted
Initial submission to the registry
October 7, 2021
CompletedFirst Posted
Study publicly available on registry
October 28, 2021
CompletedOctober 28, 2021
October 1, 2021
1.8 years
October 7, 2021
October 16, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Post tuberculosis lung functional impairment
spirometry abnormality either: restrictive, obstructive, or mixed
6 months
post tuberculosis persistent clinical symptoms
either cough , sputum , breathlessness, hemoptysis
6 months
Grading of obstruction function:
grading according to GOLD : mild , moderate , severe , very severe
6 months
Study Arms (1)
Cured pulmonary Tuberculosis patients
6 months after a completed course of anti-tuberculosis therapy
Interventions
Eligibility Criteria
Patient more than 18 years old had been newly diagnosed drug-sensitive first episode pulmonary tuberculosis, confirmed by sputum smear microscopy were included in the study. He completed an outpatient course of standard first line anti-tuberculosis therapy (6 months) and declared as cured without radiological change over the past year (in comparable with chest X-ray at the end of TB treatment).
You may qualify if:
- Patient completed an outpatient course of standard first line anti-tuberculosis therapy and declared as cured
You may not qualify if:
- Smoker (to avoid spirometry biases).
- Extrapulmonary tuberculosis cases
- Multidrug resistant tuberculosis
- known contraindications to spirometry testing
- Individuals with chest wall deformities or neuromuscular diseases
- Patients who failed to achieve acceptability and reproducibility criteria of the spirometry test
- Defaulter cases or irregular treatment,
- known coexisting chronic lung disease as history of asthma or interstitial lung diseases
- A history of illicit drug use
- Patients with comorbidities: renal and hepatic insufficiency, heart diseases and metabolic disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chest Department-faculty of medicine-Assuit university
Asyut, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecture in Chest and Tuberculosis Department, Faculty of Medicine
Study Record Dates
First Submitted
October 7, 2021
First Posted
October 28, 2021
Study Start
January 20, 2018
Primary Completion
November 1, 2019
Study Completion
February 4, 2020
Last Updated
October 28, 2021
Record last verified: 2021-10